Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04960735Not ApplicableCompleted

Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung Cancer

Role: collaborator

NCT06501404Not ApplicableCompleted

PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis

Role: collaborator

NCT05600218Unknown

RWD Patients With Pulmonary Arterial Hypertension Treated With IP Prostacyclin Receptor Agonists

Role: collaborator

NCT04092088Not ApplicableUnknown

Effects of Cerebral & Peripheral Electrical Stimulation on Pain and Function in CTS

Role: collaborator

NCT02158923Not ApplicableCompleted

Individualized Perioperative Open Lung Ventilatory Strategy

Role: collaborator

NCT01908660Completed

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Role: collaborator

NCT01577368Phase 3Completed

Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa

Role: collaborator

All 7 trials loaded